Although the randomized controlled trial (RCT) is the optimal design to determine a therapy’s safety and efficacy in many cases, it is unable to answer a broad constellation of questions healthcare stakeholders must answer to understand the value of a therapy in real-world medical practice.

Pragmatic clinical trials (PCTs) are designed to extend scientific evaluation beyond the limits of the RCT research setting and into the realm of real-world medical practice. For the life sciences industry, PCTs offer solutions to address the growing demands of care providers, payers and policy makers for high-quality evidence of therapeutic and economic value.
 

Join Mark Cziraky, Co-Founder and Vice President of Research at HealthCore, and Vince Willey, Principal Scientist at HealthCore, for a webinar exploring:

  1. The rationale and key characteristics of pragmatic clinical trials
  2. Design and infrastructure considerations for pragmatic clinical trials
  3. The opportunities, challenges, and lessons learned from real world examples of pragmatic clinical trial
 
Presenters:
 
Mark J. Cziraky, PharmD, CLS, FAHA, FNLA
Vice President of Research
HealthCore
Vince Willey, PharmD, BCACP
Principal Scientist
HealthCore
 

This email was sent on behalf of CLIENT by HealthEconomics.Com, 449 S. Mill View Way, Ponte Vedra Beach, FL 32082. If you don't wish to receive further Industry Leaders News Updates from us, you may immediately unsubscribe from this list here, or send your request in writing to the address above. Read more about our privacy policy here. You may also request a copy in writing using the address above.

REGISTRATION DOES NOT GUARANTEE ACCEPTANCE TO ATTEND THIS WEBINAR. ALL REGISTRATIONS WILL BE REVIEWED BY SPONSORING COMPANY WITHIN 48 HOURS OF RECEIPT. HEALTHECONOMICS.COM DOES NOT APPROVE OR DENY ANY REGISTRATIONS. THIS RESPONSIBILITY IS HELD SOLELY BY THE SPONSORING ORGANIZATION.